Seer

Seer Medical is reimagining how people achieve video-EEG-ECG monitoring by making it more convenient and accessible in the home environment. The company combines medical-grade wearable devices, cloud computing, and computer science to enable the transition of clinical monitoring from the hospital to the home, opening access to world-class clinical monitoring at scale. Seer Medical's platform uses EEG and ECG sensors to record small and large events, behavior changes, and visible symptoms over multiple days, integrating diverse data types including patient diaries, clinical records, medical imaging (MRI, PET, SPECT, CT), time-series data from EEG and other wearables, and video recordings. This comprehensive approach allows clinicians to capture and analyze the full spectrum of seizure activity and related physiological data in a patient's natural environment, improving diagnostic accuracy and patient comfort compared to traditional in-hospital monitoring. The company actively publishes research in peer-reviewed journals, with recent publications in Epilepsy & Behavior and Neurophysiologie Clinique covering topics such as diagnostic screening for epilepsy and functional neurological disorders, ECG feature segmentation for seizure detection, and cardiac arrhythmias in sudden unexpected death in epilepsy. Founded in 2017 and headquartered in Melbourne, Australia, Seer Medical has raised $34.0M in Series A funding from investors including The Australian health system, SGH, Cochlear, EWM Group, Giant Leap, Avalanche Technology Group, Breakthrough Victoria, and SPRIM Global Investments.